Jan Holmgren
Swedish physician, microbiologist, and immunologist
Actions of cholera toxin and the prevention and treatment of cholera.Antibodies in Human Serum and Milk Induced by Enterobacteria and Food ProteinsBacterial enteric infections and vaccine developmentCD4+CD25+ suppressor T cells regulate pathogen induced inflammation and diseaseCholera and the immune response.Cholera as a model for research on mucosal immunity and development of oral vaccinesCholera toxin - a foe & a friend.Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems.Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity.Cholera toxin structure, gene regulation and pathophysiological and immunological aspectsCpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infectionsCurrent status and future prospects for a vaccine against schistosomiasisDevelopment of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrheaDevelopment of oral vaccines against enterotoxinogenic Escherichia coli diarrhoeaEuropean Commission COST/STD Initiative. Report of the expert panel VI. Concerted efforts in the field of mucosal immunology.Exploration of mucosal immunity in humans: relevance to vaccine development.Immunological aspects of urinary tract infectionsInduction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.Mechanisms of Disease and Immunity in Cholera: A ReviewMucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.Mucosal immunisation and adjuvants: a brief overview of recent advances and challengesMucosal immunity and tolerance: relevance to vaccine developmentMucosal immunity and vaccination.Mucosal immunity and vaccinesMucosal immunity: implications for vaccine developmentMucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier.Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunitNew vaccines against bacterial enteric infectionsOral immunization against choleraRecent advances in mucosal vaccines and adjuvantsRecent developments in mucosal immunomodulatory adjuvantsReceptors for cholera toxin and Escherichia coli heat-labile enterotoxin revisited.Regulation of mammalian ornithine decarboxylaseSensitization and development of tolerance via the gut.Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.Sublingual vaccinationVaccines against enteric infections for the developing worldVirulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea
author
Jan Holmgren
Swedish physician, microbiologist, and immunologist
alternateName
Holmgren J
@en
Holmgren J.
@en
Holmgren
@en
J Holmgren
@en
J. Holmgren
@en
Jan Roland Holmgren
@en
award
birthDate
1944-01-01T00:00:00Z
gender
knowsLanguage
mainEntityOfPage
nationality
sameAs
/g/11dykmxdm
worksFor
comment
Swedish physician, microbiologist, and immunologist
@en
chercheur
@fr
dokter
@id
investigador
@es
schwedischer Arzt, Apotheker, Mikrobiologe und Immunologe
@de
wetenschapper
@nl
研究員
@ja
研究者
@zh
label
Jan Holmgren
@ast
Jan Holmgren
@ca
Jan Holmgren
@de
Jan Holmgren
@en
Jan Holmgren
@es
Jan Holmgren
@fr
Jan Holmgren
@ga
Jan Holmgren
@nl
Jan Holmgren
@sl
Jan Holmgren
@sq